FIELD: medicine. SUBSTANCE: invention relates to agents used for treatment of suppurative-inflammatory diseases. Tablets covered by acid-resistant envelope has the purified concentrate of staphylococcus, or streptococcus, or proteus, or Escherichia coli, or Pseudomonas aeruginosa or their mixture of bacteriophage and the special addition. EFFECT: enhanced effectiveness of agent, absence of unpleasant taste properties. 6 cl, 1 tbl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
AGENT FOR SUPPURATIVE-INFLAMMATORY DISEASE TREATMENT | 1995 |
|
RU2105544C1 |
METHOD OF COMPLEX POST-OPERATION TREATMENT OF POST-PERITONITIS PATIENTS | 2008 |
|
RU2371162C1 |
METHOD OF TREATING ABSCESSES IN EXPERIMENT | 2011 |
|
RU2460533C1 |
METHOD FOR TREATING POSTOPERATIONAL ABSCESSES OF ABDOMINAL CAVITY | 2004 |
|
RU2243780C1 |
BACTERIOPHAGE COMPOSITION (VERSIONS) | 2007 |
|
RU2366437C2 |
AGENT FOR TREATMENT OF TRAUMATIC INFECTIONS OF EYE ANTERIOR PART | 1996 |
|
RU2142288C1 |
BACTERICIDAL PREPARATION | 1990 |
|
RU1704462C |
IMMUNOBIOLOGICAL BACTERICIDAL PREPARATION (VERSIONS) | 2007 |
|
RU2366708C2 |
SEXTAPHAGE (PYOBACTERIOPHAGE POLYVALENT) OR BACTERIOPHAGE SALMONELLOUS PHARMACEUTICAL COMPOSITION AND METHOD FOR PRODUCING THEREOF | 2009 |
|
RU2410084C1 |
BACTERIOPHAGE-CONTAINING PHARMACEUTICAL COMPOSITION AND METHOD FOR ITS PREPARING | 2002 |
|
RU2241446C2 |
Authors
Dates
2000-01-20—Published
1997-06-30—Filed